0000899243-22-006633.txt : 20220216 0000899243-22-006633.hdr.sgml : 20220216 20220216161038 ACCESSION NUMBER: 0000899243-22-006633 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220214 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hwang Sooin CENTRAL INDEX KEY: 0001862522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39244 FILM NUMBER: 22643669 MAIL ADDRESS: STREET 1: 260 SHERIDAN AVENUE, SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vincerx Pharma, Inc. CENTRAL INDEX KEY: 0001796129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 833197402 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-800-6676 MAIL ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Vincera Pharma, Inc. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: LifeSci Acquisition Corp. DATE OF NAME CHANGE: 20191206 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-14 0 0001796129 Vincerx Pharma, Inc. VINC 0001862522 Hwang Sooin 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306 0 1 0 0 Chief Business Officer Stock Option (right to buy) 6.26 2022-02-14 4 A 0 34000 0.00 A 2032-02-13 Common Stock 34000 34000 D Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter. By: /s/ Sooin Hwang 2022-02-16